Laurie Milner
Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Membrane Proteins | 8 | 1994 | 233 |
Why?
| Receptors, Cell Surface | 7 | 1994 | 115 |
Why?
| Gastrointestinal Tract | 1 | 2011 | 26 |
Why?
| Methylprednisolone | 1 | 2011 | 41 |
Why?
| Graft vs Host Disease | 3 | 1998 | 29 |
Why?
| Hematopoiesis | 4 | 1994 | 47 |
Why?
| Hepatoblastoma | 1 | 2009 | 2 |
Why?
| Glucocorticoids | 1 | 2011 | 107 |
Why?
| Tooth Eruption | 1 | 2009 | 16 |
Why?
| Cysts | 1 | 2009 | 32 |
Why?
| Transcription Factors | 5 | 1994 | 201 |
Why?
| Mouth Diseases | 1 | 2009 | 19 |
Why?
| Hematopoietic Stem Cells | 6 | 1994 | 69 |
Why?
| Liver Neoplasms | 1 | 2009 | 97 |
Why?
| Liver | 1 | 2011 | 248 |
Why?
| Granulocytes | 2 | 1996 | 46 |
Why?
| Granulocyte Colony-Stimulating Factor | 2 | 1998 | 34 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1998 | 53 |
Why?
| Dictyostelium | 4 | 1979 | 3 |
Why?
| Trans-Activators | 2 | 1999 | 113 |
Why?
| Infant | 4 | 1998 | 464 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 121 |
Why?
| Receptor, Notch1 | 5 | 1994 | 10 |
Why?
| Receptors, Notch | 3 | 1999 | 30 |
Why?
| Drosophila | 1 | 1994 | 32 |
Why?
| Osteoblasts | 2 | 2003 | 39 |
Why?
| Remission Induction | 2 | 1998 | 64 |
Why?
| Antigens, CD | 1 | 1994 | 128 |
Why?
| Injections, Intra-Arterial | 1 | 2011 | 28 |
Why?
| Hematopoietic Stem Cell Transplantation | 2 | 2003 | 49 |
Why?
| Gene Expression | 2 | 1994 | 291 |
Why?
| Drug Resistance | 1 | 2011 | 83 |
Why?
| Medical Records | 1 | 2011 | 104 |
Why?
| Molecular Sequence Data | 7 | 1992 | 404 |
Why?
| Amifostine | 1 | 2010 | 15 |
Why?
| Cytoprotection | 1 | 2010 | 32 |
Why?
| Serine Endopeptidases | 2 | 1980 | 28 |
Why?
| Endopeptidases | 2 | 1980 | 46 |
Why?
| Receptor, Notch2 | 3 | 1996 | 2 |
Why?
| Calcium-Binding Proteins | 3 | 1998 | 49 |
Why?
| Intercellular Signaling Peptides and Proteins | 3 | 1998 | 64 |
Why?
| Lymphoma | 1 | 2010 | 96 |
Why?
| Parathyroid Hormone | 2 | 2003 | 36 |
Why?
| Bone Marrow Transplantation | 2 | 1998 | 90 |
Why?
| Neoplasm Staging | 1 | 2009 | 125 |
Why?
| Amino Acid Sequence | 4 | 1996 | 319 |
Why?
| Severity of Illness Index | 1 | 2011 | 358 |
Why?
| Humans | 11 | 1992 | 1856 |
Why?
| Liver Transplantation | 1 | 2009 | 54 |
Why?
| Retrospective Studies | 2 | 1998 | 653 |
Why?
| Animals | 10 | 1994 | 1031 |
Why?
| Male | 6 | 1992 | 1553 |
Why?
| Mice | 7 | 1996 | 623 |
Why?
| Cell Differentiation | 4 | 1996 | 262 |
Why?
| Child | 2 | 2002 | 749 |
Why?
| Cloning, Molecular | 3 | 1998 | 183 |
Why?
| Polymerase Chain Reaction | 2 | 1994 | 279 |
Why?
| Immunoglobulin Variable Region | 2 | 1992 | 22 |
Why?
| Immunoglobulin Heavy Chains | 2 | 1992 | 24 |
Why?
| Histocompatibility | 1 | 2002 | 15 |
Why?
| Rodent Diseases | 1 | 2001 | 6 |
Why?
| Severe Combined Immunodeficiency | 1 | 2001 | 9 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2002 | 33 |
Why?
| Serine | 1 | 2001 | 62 |
Why?
| Glucosephosphates | 1 | 1980 | 2 |
Why?
| Acetylglucosamine | 1 | 1980 | 5 |
Why?
| Glucosamine | 1 | 1980 | 11 |
Why?
| Hexosaminidases | 1 | 1980 | 6 |
Why?
| Acetylglucosaminidase | 1 | 1980 | 4 |
Why?
| Transplantation Conditioning | 3 | 1998 | 23 |
Why?
| Adult | 3 | 1998 | 1317 |
Why?
| Bone Marrow Cells | 2 | 1998 | 92 |
Why?
| Female | 6 | 1992 | 1643 |
Why?
| Middle Aged | 2 | 2010 | 1161 |
Why?
| Embryonic and Fetal Development | 1 | 2000 | 52 |
Why?
| Histocompatibility Antigens Class II | 1 | 2001 | 50 |
Why?
| Epitopes | 1 | 1980 | 86 |
Why?
| Peptide Hydrolases | 2 | 1979 | 38 |
Why?
| Protein Processing, Post-Translational | 1 | 2000 | 78 |
Why?
| Mammals | 1 | 1999 | 47 |
Why?
| Cell Division | 2 | 1996 | 273 |
Why?
| Kinetics | 3 | 1979 | 349 |
Why?
| Phosphorylation | 1 | 2001 | 224 |
Why?
| Ligands | 3 | 2000 | 116 |
Why?
| Cell Line | 3 | 1992 | 375 |
Why?
| Mice, Knockout | 1 | 2001 | 265 |
Why?
| Leukemia, Myeloid | 1 | 1998 | 37 |
Why?
| Nuclear Proteins | 1 | 2001 | 139 |
Why?
| Myelodysplastic Syndromes | 1 | 1998 | 27 |
Why?
| Protein Sorting Signals | 1 | 1996 | 19 |
Why?
| Signal Transduction | 2 | 2001 | 313 |
Why?
| Retroviridae | 1 | 1996 | 36 |
Why?
| Morphogenesis | 1 | 1996 | 47 |
Why?
| Chromosomes, Human, Pair 14 | 2 | 1992 | 14 |
Why?
| Binding Sites | 1 | 1998 | 213 |
Why?
| Chromosome Mapping | 2 | 1992 | 107 |
Why?
| Base Sequence | 3 | 1992 | 371 |
Why?
| Rats | 4 | 1998 | 530 |
Why?
| Antigens, CD34 | 1 | 1994 | 26 |
Why?
| Mice, Inbred C57BL | 3 | 2000 | 318 |
Why?
| Phosphoproteins | 2 | 1979 | 86 |
Why?
| Recombinant Proteins | 1 | 1996 | 290 |
Why?
| Models, Biological | 1 | 1999 | 410 |
Why?
| Transfection | 1 | 1996 | 237 |
Why?
| Genes, Immunoglobulin | 1 | 1992 | 28 |
Why?
| Whole-Body Irradiation | 2 | 2001 | 43 |
Why?
| Fetus | 1 | 1992 | 105 |
Why?
| Pancytopenia | 1 | 2010 | 13 |
Why?
| Maximum Tolerated Dose | 1 | 2010 | 18 |
Why?
| Mucositis | 1 | 2010 | 12 |
Why?
| Melphalan | 1 | 2010 | 24 |
Why?
| Stromal Cells | 2 | 1998 | 41 |
Why?
| Peripheral Blood Stem Cell Transplantation | 1 | 2010 | 17 |
Why?
| Carmustine | 1 | 2010 | 25 |
Why?
| Etoposide | 1 | 2010 | 37 |
Why?
| Cytarabine | 1 | 2010 | 32 |
Why?
| Transplantation, Autologous | 1 | 2010 | 78 |
Why?
| Disease-Free Survival | 2 | 1998 | 102 |
Why?
| Atrial Fibrillation | 1 | 2010 | 40 |
Why?
| Sequence Homology, Amino Acid | 2 | 1998 | 156 |
Why?
| Combined Modality Therapy | 1 | 2010 | 219 |
Why?
| Recurrence | 2 | 1998 | 261 |
Why?
| Protein Structure, Tertiary | 2 | 1998 | 163 |
Why?
| Dose-Response Relationship, Drug | 1 | 2010 | 431 |
Why?
| Gene Deletion | 2 | 1992 | 121 |
Why?
| Young Adult | 1 | 2010 | 380 |
Why?
| Immunoelectrophoresis | 2 | 1979 | 20 |
Why?
| Adenylate Cyclase | 1 | 2006 | 24 |
Why?
| Postoperative Complications | 1 | 2010 | 305 |
Why?
| MAP Kinase Signaling System | 1 | 2006 | 56 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 62 |
Why?
| Protein Kinase C | 1 | 2006 | 93 |
Why?
| Enzyme Activation | 1 | 2006 | 177 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2003 | 9 |
Why?
| Receptors, Parathyroid Hormone | 1 | 2003 | 10 |
Why?
| Environment | 1 | 2003 | 43 |
Why?
| Cell Line, Tumor | 1 | 2006 | 208 |
Why?
| Cell Count | 1 | 2003 | 163 |
Why?
| Oligonucleotide Probes | 2 | 1992 | 40 |
Why?
| Gene Rearrangement | 2 | 1992 | 26 |
Why?
| Treatment Outcome | 2 | 1998 | 661 |
Why?
| Threonine | 1 | 2001 | 27 |
Why?
| Colony-Forming Units Assay | 1 | 2001 | 27 |
Why?
| Cell Survival | 1 | 2003 | 229 |
Why?
| Immunoblotting | 1 | 2001 | 119 |
Why?
| Mice, Transgenic | 1 | 2003 | 209 |
Why?
| Phosphoserine | 1 | 1980 | 14 |
Why?
| Papain | 1 | 1980 | 5 |
Why?
| Receptors, Cytokine | 1 | 2000 | 8 |
Why?
| Immunodiffusion | 1 | 1980 | 30 |
Why?
| Amino Acids | 1 | 2001 | 108 |
Why?
| Germ-Line Mutation | 1 | 2000 | 22 |
Why?
| Microscopy, Fluorescence | 1 | 2001 | 137 |
Why?
| Fetal Death | 1 | 2000 | 30 |
Why?
| Immunoglobulins | 1 | 2000 | 54 |
Why?
| Cross Reactions | 1 | 1980 | 63 |
Why?
| Homozygote | 1 | 2000 | 68 |
Why?
| Bone and Bones | 1 | 2003 | 99 |
Why?
| Gene Targeting | 1 | 2000 | 51 |
Why?
| Proteins | 1 | 2003 | 192 |
Why?
| Plasmids | 1 | 2001 | 122 |
Why?
| Alleles | 1 | 2000 | 108 |
Why?
| Transcriptional Activation | 1 | 2001 | 99 |
Why?
| In Situ Hybridization | 1 | 2000 | 135 |
Why?
| Embryo, Mammalian | 1 | 2000 | 99 |
Why?
| Point Mutation | 1 | 2000 | 122 |
Why?
| Karnofsky Performance Status | 1 | 1998 | 12 |
Why?
| Blotting, Western | 1 | 2001 | 275 |
Why?
| Flow Cytometry | 1 | 2001 | 216 |
Why?
| Growth Disorders | 1 | 1998 | 26 |
Why?
| Salvage Therapy | 1 | 1998 | 37 |
Why?
| Age Factors | 1 | 2002 | 480 |
Why?
| Treatment Failure | 1 | 1998 | 88 |
Why?
| Prognosis | 1 | 2002 | 388 |
Why?
| Aged | 1 | 2010 | 988 |
Why?
| Cause of Death | 1 | 1998 | 82 |
Why?
| Transplantation, Homologous | 1 | 1998 | 94 |
Why?
| Cytokines | 1 | 2001 | 207 |
Why?
| Phenotype | 1 | 2000 | 303 |
Why?
| Disease Models, Animal | 1 | 2001 | 349 |
Why?
| COS Cells | 1 | 1998 | 73 |
Why?
| Mutation | 1 | 2003 | 340 |
Why?
| Protein Binding | 1 | 1980 | 256 |
Why?
| Prospective Studies | 1 | 2002 | 545 |
Why?
| DNA, Complementary | 1 | 1998 | 139 |
Why?
| Acute Disease | 1 | 1998 | 271 |
Why?
| Survival Analysis | 1 | 1998 | 205 |
Why?
| Survival Rate | 1 | 1998 | 250 |
Why?
| Antineoplastic Agents | 1 | 2002 | 190 |
Why?
| Child, Preschool | 1 | 2002 | 554 |
Why?
| Risk Factors | 1 | 2002 | 555 |
Why?
| Cells, Cultured | 1 | 2001 | 447 |
Why?
| Time Factors | 1 | 2001 | 896 |
Why?
| Immunoglobulin Joining Region | 1 | 1992 | 5 |
Why?
| Genomic Library | 1 | 1992 | 11 |
Why?
| Electrophoresis, Gel, Pulsed-Field | 1 | 1992 | 17 |
Why?
| Cell Transformation, Viral | 1 | 1992 | 35 |
Why?
| Adolescent | 1 | 2002 | 891 |
Why?
| Blotting, Southern | 1 | 1992 | 69 |
Why?
| Nucleic Acid Hybridization | 1 | 1992 | 94 |
Why?
| UTP-Glucose-1-Phosphate Uridylyltransferase | 1 | 1979 | 1 |
Why?
| Uridine Diphosphate Glucose | 1 | 1979 | 1 |
Why?
| Uridine Triphosphate | 1 | 1979 | 4 |
Why?
| Precipitin Tests | 1 | 1979 | 81 |
Why?
| DNA | 1 | 1992 | 262 |
Why?
|
|
Milner's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
